GSK plc

Insider Reports History

Location
London
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GSK plc:

Company Role Class Num Shares Value Price $ Report Date Ownership
Wave Life Sciences Ltd. 10%+ Owner Ordinary Shares 18,245,691 $346,668,129 $19.00 11 Dec 2025 By Corporation
Lyell Immunopharma, Inc. 10%+ Owner Common Stock 30,253,189 $68,977,271 $2.28 21 Jun 2021 Indirect
CVRx, Inc. 10%+ Owner Common Stock 1,007,583 $18,695,602 $18.55 02 Jul 2021 Indirect
Spero Therapeutics, Inc. 10%+ Owner Common Stock 9,190,606 $11,672,070 $1.27 07 Nov 2022 Indirect
CVRx, Inc. 10%+ Owner Series B-2 Preferred Stock 0 02 Jul 2021 Indirect
CVRx, Inc. 10%+ Owner Series C-2 Preferred Stock 0 02 Jul 2021 Indirect
CVRx, Inc. 10%+ Owner Series D-2 Preferred Stock 0 02 Jul 2021 Indirect
CVRx, Inc. 10%+ Owner Series E-2 Preferred Stock 0 02 Jul 2021 Indirect
CVRx, Inc. 10%+ Owner Series F-2 Preferred Stock 0 02 Jul 2021 Indirect
CVRx, Inc. 10%+ Owner Series G Preferred Stock 0 02 Jul 2021 Indirect
Innoviva, Inc. 10%+ Owner Common Stock 0 $16.05 20 May 2021 Indirect
Lyell Immunopharma, Inc. 10%+ Owner Series AA Preferred Stock 0 21 Jun 2021 Indirect
Theravance Biopharma, Inc. Former 10% Owner Ordinary Shares 0 $10.29 16 Sep 2022 By Corporation
Theravance Biopharma, Inc. Former 10% Owner Exchangeable Senior Notes due 2023 0 16 Sep 2022 Indirect

Insider Reports Filed by GSK plc

Symbol Company Period Transactions Value $ Form Type Role Filing Time
WVE Wave Life Sciences Ltd. 11 Dec 2025 1 +$27,930,000 4 10%+ Owner 15 Dec 2025, 16:32
WVE Wave Life Sciences Ltd. 27 Sep 2024 1 +$22,335,440 4 10%+ Owner 01 Oct 2024, 17:54
WVE Wave Life Sciences Ltd. 07 Dec 2023 1 +$16,500,000 4 10%+ Owner 30 Jan 2024, 16:39
WVE Wave Life Sciences Ltd. 23 Jan 2023 0 $0 3 10%+ Owner 30 Jan 2023, 15:34
SPRO Spero Therapeutics, Inc. 07 Nov 2022 0 $0 3 10%+ Owner 14 Nov 2022, 16:05
TBPH Theravance Biopharma, Inc. 16 Sep 2022 2 +$175,024,132 4 Former 10% Owner 20 Sep 2022, 16:16
CVRX CVRx, Inc. 02 Jul 2021 13 +$4,950,000 4 10%+ Owner 06 Jul 2021, 16:38
CVRX CVRx, Inc. 29 Jun 2021 0 $0 3 10%+ Owner 06 Jul 2021, 16:22
LYEL Lyell Immunopharma, Inc. 21 Jun 2021 2 $0 4 10%+ Owner 23 Jun 2021, 18:14
MEHCQ 23andMe Holding Co. 16 Jun 2021 0 $0 3 10%+ Owner 04 Nov 2022, 16:11
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 17 Jun 2021, 17:56
INVA Innoviva, Inc. 20 May 2021 1 -$392,064,435 4 10%+ Owner 24 May 2021, 17:04